Home › Liposarcoma › New York
Liposarcoma clinical trials in New York
7 studies for Liposarcoma are looking for participants at sites in New York.
Cities in New York
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
- Roswell Park Cancer Institute, Buffalo
- Northwell Health/Center for Advanced Medicine, Lake Success
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- and 8 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06422806STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
- Northwell Health Cancer Institute, Lake Success
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT06975293A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 16 to 70 · All sexes · Updated Oct 9, 2026 · NCT07741877Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- Roswell Park Cancer Institute, Buffalo
- Northwell Health/Center for Advanced Medicine, Lake Success
- North Shore University Hospital, Manhasset
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT04031677A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06881992A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
- Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06843967A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
- Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT07089992From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.